Former Attorney General Pam Bondi Undergoes Thyroid Cancer Treatment

On May 27, 2026, former U.S. Attorney General Pam Bondi publicly announced a diagnosis of thyroid cancer. The cancer was discovered shortly after she was dismissed from her post by President Ronald Donald Trump in early April. Bondi, who was 60, confirmed that she had undergone surgery a few weeks prior and is currently receiving additional treatment.

Thyroid cancer is one of the most treatable cancers, with a five‑year survival rate above 98 percent. Most cases are curable with surgery and, when necessary, additional therapy. Dr. Ashish Jha, a professor of public health, noted that the outlook is favorable for patients receiving timely care.

Despite her health challenges, Bondi has accepted an invitation to join the White House’s newly formed Presidential Council of Advisors on Science and Technology (PCAST). The council, established by executive order in January 2025, aims to bring together experts from academia, industry, and government to guide national science and technology policy.

Following her appointment to PCAST, Bondi is slated to testify before the House Oversight Committee on Friday. She will discuss the handling of the Jeffrey Epstein documentation that marked a significant point in her tenure at the Justice Department. The testimony arrives amid ongoing scrutiny over the Department’s compliance with release requirements for the Epstein files.

Former Deputy Attorney General Todd Blanche has been serving in an acting capacity since Bondi’s departure. The Justice Department has also initiated an internal audit to review compliance with federal regulations regarding disclosure of the Epstein records.

Commentators have noted Bondi’s resilience. Former podcast host and White House adviser Katie Miller praised Bondi’s “quiet perseverance” in the face of her diagnosis. Vice‑President JD Vance described Bondi as an “enormously valuable asset,” emphasizing her ongoing contribution to national policy discussions.

Bondi’s journey reflects a broader narrative about public officials managing personal health while navigating demanding roles. Her case underscores the importance of medical support systems for high‑profile government figures and the capacity for continued public service despite health setbacks.